ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NTP Establishes Panel To Write New Guidelines For Detection, Evaluation Of Chemical Carcinogens

April 1, 1983

Miami Radiotherapy Program Defended

June 30, 1978

University of Oklahoma Wins Planning Grant; Three Mile Island Follow-Up Finds No Significant Increase In Cancer Deaths

November 2, 2002

José Baselga Named Physician-in-Chief Of Memorial Sloan-Kettering Hospital

September 21, 2012

SmithKline Seeks FDA Action Against Homeopathic Smoking-Cessation Gum

March 6, 1998

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998